Robert F. Struck

2.4k total citations
100 papers, 2.0k citations indexed

About

Robert F. Struck is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Robert F. Struck has authored 100 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Organic Chemistry and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Robert F. Struck's work include Chemotherapy-induced organ toxicity mitigation (18 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Chemical Reactions and Isotopes (12 papers). Robert F. Struck is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (18 papers), Pharmacogenetics and Drug Metabolism (15 papers) and Chemical Reactions and Isotopes (12 papers). Robert F. Struck collaborates with scholars based in United States, Germany and France. Robert F. Struck's co-authors include Donald L. Hill, Marion Kirk, Hira L. Gurtoo, W R Laster, Anthony J. Marinello, J. Arly Nelson, John A. Montgomery, Y. Fulmer Shealy, William R. Waud and Tzu-Wen Shih and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Robert F. Struck

99 papers receiving 1.8k citations

Peers

Robert F. Struck

ONCOL

PHARM

PFM

Joseph B. Guttenplan United States

Amin A. Nomeir United States

Hira L. Gurtoo United States

William E. Fahl United States

Janeric Seidegård Sweden

Elizabeth G. Snyderwine United States

Vincent T. Oliverio United States

P. Bentley Switzerland

Peter J. Wirth United States

S.S. Thorgeirsson United States

Joseph B. Guttenplan United States

Robert F. Struck

1.1k ×1.6

424 ×1.1

ONCOL

117 ×0.3

PHARM

671 ×1.9

436 ×1.3

PFM

Citations per year, relative to Robert F. Struck Robert F. Struck (= 1×) peers Joseph B. Guttenplan

Countries citing papers authored by Robert F. Struck

Since Specialization

Citations

This map shows the geographic impact of Robert F. Struck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert F. Struck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert F. Struck more than expected).

Fields of papers citing papers by Robert F. Struck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert F. Struck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert F. Struck. The network helps show where Robert F. Struck may publish in the future.

Co-authorship network of co-authors of Robert F. Struck

This figure shows the co-authorship network connecting the top 25 collaborators of Robert F. Struck. A scholar is included among the top collaborators of Robert F. Struck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert F. Struck. Robert F. Struck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morgan, Lee Roy, et al.. (2009). Carbonate and carbamate derivatives of 4-demethylpenclomedine as novel anticancer agents. Cancer Chemotherapy and Pharmacology. 64(4). 829–835. 14 indexed citations

Germann, N., Saı̈k Urien, Marion S. Ratterree, et al.. (2004). Comparative preclinical toxicology and pharmacology of isophosphoramide mustard, the active metabolite of ifosfamide. Cancer Chemotherapy and Pharmacology. 55(2). 143–151. 11 indexed citations

Struck, Robert F., et al.. (2001). Acyl derivatives of demethylpenclomedine, an antitumor-active, non-neurotoxic metabolite of penclomedine. Cancer Chemotherapy and Pharmacology. 48(1). 47–52. 4 indexed citations

O’Reilly, Séamus, L B Grochow, Ross C. Donehower, et al.. (1997). Phase I and pharmacologic study of penclomedine, a novel alkylating agent, in patients with solid tumors.. Journal of Clinical Oncology. 15(5). 1974–1984. 9 indexed citations

Mudipalli, Anuradha, Alexander E. Maccubbin, Srikanth S. Nadadur, Robert F. Struck, & Hira L. Gurtoo. (1997). Mutations induced by monofunctional and bifunctional phosphoramide mustards in supF tRNA gene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 381(1). 49–57. 1 indexed citations

Struck, Robert F., et al.. (1997). Quantification of 4-hydroxyifosfamide in plasma of ifosfamide-treated mice. Cancer Chemotherapy and Pharmacology. 40(1). 57–59. 2 indexed citations

Struck, Robert F., Steven M. Schmid, & William R. Waud. (1994). Antitumor activity of halogen analogs of phosphoramide, isophosphoramide, and triphosphoramide mustards, the cytotoxic metabolites of cyclophosphamide, ifosfamide, and trofosfamide. Cancer Chemotherapy and Pharmacology. 34(3). 191–196. 12 indexed citations

Maccubbin, Alexander E., Laura Lee, Robert F. Struck, & Hira L. Gurtoo. (1992). 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion. Chemico-Biological Interactions. 84(1). 21–35. 5 indexed citations

Alberts, David S., Patricia M. Plezia, Denise J. Roe, et al.. (1991). Lack of Ranitidine Effects on Cyclophosphamide Bon Marrow Toxicity or Metabolism: A Placebo-Controlled Clinical Trial. JNCI Journal of the National Cancer Institute. 83(23). 1739–1743. 4 indexed citations

10.

Struck, Robert F., et al.. (1991). Identification of 7-(2-hydroxyethyl)guanine as a product of alkylation of calf thymus DNA with Clomesone. Biochemical Pharmacology. 41(3). 457–459. 3 indexed citations

11.

Ataya, Khalid M., et al.. (1990). The Uptake and Metabolism of Cyclophosphamide by the Ovary. PubMed. 6(2). 83–92. 10 indexed citations

12.

Maccubbin, A. E., et al.. (1990). ³²P-Postlabeling Analysis of Binding of the Cyclophosphamide Metabolite, Acrolein, to DNA. PubMed. 2(6). 207–211. 10 indexed citations

13.

Ataya, Khalid M., et al.. (1988). The effect of “activated” cyclophosphamide on rat granulosa cells in vitro. Reproductive Toxicology. 2(2). 99–103. 22 indexed citations

14.

McCarthy, Dennis J., et al.. (1982). Disposition and metabolism of the carcinogen reduced Michler's ketone in rats.. PubMed. 42(9). 3475–9. 5 indexed citations

15.

Struck, Robert F., Donald J. Dykes, W R Laster, & Jane Montgomery. (1980). Isophosphoramide mustard (ipm), a non-urotoxic metabolite of the clinical antitumor agent ifosfamide (ifa) with activity against murine tumors comparable to cyclophosphamide (cpa). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 290. 1 indexed citations

16.

Struck, Robert F., et al.. (1980). Disposition of 9-beta-D-arabinofuranosyl-2-fluoroadenine in mice, dogs, and monkeys.. Drug Metabolism and Disposition. 8(2). 60–63. 6 indexed citations

17.

Hill, Donald L., Tzu-Wen Shih, & Robert F. Struck. (1979). Macromolecular binding and metabolism of the carcinogen 4-chloro-2-methylaniline.. PubMed. 39(7 Pt 1). 2528–31. 7 indexed citations

18.

Hill, Donald L., Tzu-Wen Shih, Thomas P. Johnston, & Robert F. Struck. (1978). Macromolecular binding and metabolism of the carcinogen 1,2-dibromoethane.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(8). 2438–42. 100 indexed citations

19.

Brockman, R W, Sue C. Shaddix, Doris J. Adamson, & Robert F. Struck. (1975). Inhibition of growth and of dna synthesis in adenocarcinoma 755 cells in culture by 3,6-bis(5-chloro-2-piperidyl)-2, 5-piperazinedione (nsc 135758) and evidence for its alkylating activity. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

20.

Struck, Robert F., et al.. (1972). Investigation of the synthesis of aldophosphamide (ap) a toxic metabolite of cyclophosphamide (ctx). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact